The worlds first case of "Super Gonorrhea" is resistant to two crucial anti-biotics, cerftriaxone and azithryomcyin.

This week, LetsGetChecked tells you everything you need to know about "Super Gonorrhea".


Contents


Health Warning


A warning has been issued by health officials surrounding a strain of "super gonorrhea", also known as Neisseria gonorrhoeae that is resistant to a number of routine antibiotics cerftriaxone and azithryomcyin.

An English national recently contracted the super gonorrhea strain in south east Asia, resulting in an alert being issued about the possible spread of the treatment resistant bug.

Super Gonorrhea has presented itself as resistant to high-level azithromycin and ceftriaxone resistant gonorrhoea. Gonorrhea is the second most common STI in the UK, following chlamydia. If this strain of gonorrhea becomes prominent, it could become an untreatable disease.


Resistance to Previous Antibiotic Treatments


This gonorrhea superbug has been seen before, and was defeated by scientists using the closthioamide antibiotic. However, this particular antibiotic is not yet available for patients for at least another five years.

The UK patient diagnosed with super gonorrhea will be retested next month, and is being treated daily with injections of an antibiotic called ertapenem.

Each year, over 35,000 people are infected with gonorrhea in England alone, with a total of 78 million cases worldwide.


Learn more about gonorrhea and the growing resistance to antibiotics with Dr. Dominic Rowley:


For more information, visit LetsGetChecked


Written by Hannah Kingston | Approved by Medical Director Dominic Rowley